Molecular Mechanisms of Ischemic Preconditioning with Cardiovascular Aging in Elderly Patients with Arterial Hypertension

Abstract

The purpose of this study was to analyze molecular mechanisms of ischemic preconditioning (IPC) with cardiovascular aging in elderly patients with isolated systolic hypertension (ISH). The study included 306 persons divided into two groups: Group 1 (the control group) included 150 elderly patients without AH, and Group 2 (the experimental group) included 156 elderly patients with ISH according to the inclusion/exclusion criteria. The duration of ISH was 13.5 years. All patients received a double combination of antihypertensive drugs. We applied standard methods for identification of ISH and secondary hypertension. Molecular phenotyping of blood plasma with the identification of molecules involved in IPC process were processed with methods of proteomics. The data of the molecular interactions and functional features of proteins were received with STRING 10.0 database. Bioinformatics analysis has revealed the presence of molecules that are the participants in the pathways of IPC, cardiovascular aging and the molecular interactions involved. (Int J Biomed. 2016;6(1):60-64.).

Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review

“…1 ). Indeed, aging shows a remarkable impact on both cardiac structure and vasculature leading to pathological abnormalities, such as endothelial dysfunction, left ventricular (LV) hypertrophy, impaired LV diastolic function, as well as increased arterial thickening and stiffness, contributing to hypertension, coronary heart disease (CHD), myocardial infarction (MI), and stroke, until the onset of heart failure [ 55 ]. Thus, SARS-CoV-2 infection might be cause of worsening of clinical conditions in elderly patients by impacting on prior structural heart diseases through different putative molecular mechanisms, such as direct myocardial and endothelial binding, T cell death (lymphopenia), and exacerbated inflammation leading to complications in micro- and macrovascular domains, multiorgan dysfunction (MOF), and death ( Fig.…”

Effectiveness of Personalized Therapy of Arterial Hypertension

“…), белки (цитокины и ростовые пептидные фак-торы), низкомолекулярные соединения (оксид азота) Молекулярный патогенез структурно-геометрических изменений в миокарде и сосудистой стенке пожилого человека, приводящий к появлению ИСАГ, не может быть описан только на основе стандартных методов клинического исследования [14,15].…”